Avascent Revenue and Competitors

Location

N/A

Total Funding

Consulting

Industry

Estimated Revenue & Valuation

  • Avascent's estimated annual revenue is currently $105M per year.(i)
  • Avascent's estimated revenue per employee is $275,000

Employee Data

  • Avascent has 382 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4M264%N/AN/A
#2
$14.3M7226%N/AN/A
#3
$37.5M1554%N/AN/A
#4
$28.2M12858%N/AN/A
#5
$11.1M5660%N/AN/A
#6
$6M3421%N/AN/A
#7
$7.9M4555%N/AN/A
#8
$17.8M8137%N/AN/A
#9
$6.5M37-53%N/AN/A
#10
$0.7M6-79%N/AN/A
Add Company

Management Consulting

keywords:N/A

N/A

Total Funding

382

Number of Employees

$105M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avascent News

2022-04-06 - Source: BIW president out after 'violating corporate policy'

The shipyard remains in good hands, according to Jay Korman, managing director of The Avascent Group in Washington, D.C. With the long lead...

2022-03-22 - Vanda de la Mata, Rachel Jenkins, and Joe Walsh named ...

WASHINGTON, March 29, 2022 (GLOBE NEWSWIRE) -- Avascent, a strategy consultancy serving government-driven markets, celebrated its 15th...

2016-02-23 - Four Counter-Drone Technologies We Need Now

Joshua Pavluk Contributor Joshua Pavluk is a principal at Avascent. August Cole Contributor August Cole is a writer-in-residence at Avascent. More posts by this contributor When The Pentagon Comes Knocking: An Open Letter To Silicon Valley As innovation goes, the idea of a trained bird of p ...

2015-10-05 - When The Pentagon Comes Knocking: An Open Letter To Silicon Valley

Christopher Meissner Contributor Christopher Meissner is a senior associate at Avascent specializing in growth strategies for technology companies operating within government-driven markets. August Cole Contributor August Cole is a writer-in-residence at Avascent. More posts by this contribu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$86M382N/AN/A
#2
$86M382N/AN/A
#3
$76.8M384N/AN/A
#4
$15M386N/AN/A
#5
$67.6M3869%N/A